Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease

Neurobiology of Aging

Volumn 36, Issue 5, 2015, Pages 1964-1968

  Karch, André ^a,b,c   Hermann, Peter ^b   Ponto, Claudia ^b   Schmitz, Matthias ^b,d   Arora, Amandeep ^b   Zafar, Saima ^b   Llorens, Franc ^b,d   Müller Heine, Annika ^e   Zerr, Inga ^b,d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c Center for Experimental and Clinical Infection Research   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Biomarker; Creutzfeldt Jakob disease; Neurodegeneration; Subtype; Tau

Indexed keywords

PRION PROTEIN; TAU PROTEIN; BIOLOGICAL MARKER; CODON; PRION;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECEIVER OPERATING CHARACTERISTIC; SPORADIC CREUTZFELDT JAKOB DISEASE; CEREBROSPINAL FLUID; CLASSIFICATION; CREUTZFELDT-JAKOB SYNDROME; DISEASE COURSE; GENETICS; MIDDLE AGED; PRION; PROGNOSIS;

AGED; BIOMARKERS; CODON; CREUTZFELDT-JAKOB SYNDROME; DISEASE PROGRESSION; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PRIONS; PROGNOSIS; TAU PROTEINS;

EID: 84933178304     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.01.021     Document Type: Article

References (12)

1. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
2. Gmitterova K., Heinemann U., Bodemer M., Krasnianski A., Meissner B., Kretzschmar H.A., Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol. Aging 2009, 30:1842-1850.
3. Heinemann U., Krasnianski A., Meissner B., Varges D., Kallenberg K., Schulz-Schaeffer W.J., Steinhoff B.J., Grasbon-Frodl E.M., Kretzschmar H.A., Zerr I. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007, 130(Pt 5):1350-1359.
4. Kovacs G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., van Duijn C., Collins S.J., Boyd A., Giulivi A., Coulthart M., Delasnerie-Laupretre N., Brandel J.P., Zerr I., Kretzschmar H.A., de Pedro-Cuesta J., Calero-Lara M., Glatzel M., Aguzzi A., Bishop M., Knight R., Belay G., Will R., Mitrova E. Genetic prion disease: the EUROCJD experience. Hum. Genet. 2005, 118:166-174.
5. Meissner B., Kallenberg K., Sanchez-Juan P., Collie D., Summers D.M., Almonti S., Collins S.J., Smith P., Cras P., Jansen G.H., Brandel J.P., Coulthart M.B., Roberts H., Van Everbroeck B., Galanaud D., Mellina V., Will R.G., Zerr I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009, 72:1994-2001.
6. Otto M., Wiltfang J., Cepek L., Neumann M., Mollenhauer B., Steinacker P., Ciesielczyk B., Schulz-Schaeffer W., Kretzschmar H.A., Poser S. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002, 58:192-197.
7. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sima A.A., Trojanowski J.Q., Petersen R.B., Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 1996, 39:767-778.
8. Puoti G., Bizzi A., Forloni G., Safar J.G., Tagliavini F., Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012, 11:618-628.
9. Puoti G., Giaccone G., Rossi G., Canciani B., Bugiani O., Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP (Sc) in the same brain. Neurology 1999, 53:2173-2176.
10. Schmidt C., Karch A., Artjomova S., Hoeschel M., Zerr I. Pre-progression rates in Alzheimer's disease revisited. J.Alzheimers Dis. 2013, 35:451-454.
11. Uro-Coste E., Cassard H., Simon S., Lugan S., Bilheude J.M., Perret-Liaudet A., Ironside J.W., Haik S., Basset-Leobon C., Lacroux C., Peoch K., Streichenberger N., Langeveld J., Head M.W., Grassi J., Hauw J.J., Schelcher F., Delisle M.B., Andreoletti O. Beyond PrP res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog. 2008, 4:e1000029.
12. Zerr I., Kallenberg K., Summers D.M., Romero C., Taratuto A., Heinemann U., Breithaupt M., Varges D., Meissner B., Ladogana A., Schuur M., Haik S., Collins S.J., Jansen G.H., Stokin G.B., Pimentel J., Hewer E., Collie D., Smith P., Roberts H., Brandel J.P., van Duijn C., Pocchiari M., Begue C., Cras P., Will R.G., Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009, 132(Pt 10):2659-2668.